Professional Activities

  • Professor: 05/2015 – present University  of  Cape  Town,  Faculty  of  Health  Sciences,  Institute  of Infectious Disease and Molecular Medicine, Observatory, South Africa
  • South Africa, Tier 1 South African Research Chair in Cancer Biotechnology: 04/2015 - present      University of Cape Town, Faculty of Health Sciences, Department of Integrative Biomedical Sciences, Observatory, SA.
  • Co-Founder: 04/2014 - present CURIT Biotech  Holding  GmbH (HRB  16028), Mönchengladbach, Germany
  • Co-Founder: 11/2003 - present Pharmedartis GmbH (HRB 13916), Aachen, Germany
  • University Professor, Head, Dept. of Experimental Medicine and Immunotherapy:  06/2006 - 03/2015Institute for Applied Medical Engineering, Aachen, Germany
  • Head, Division of Molecular Biology: 10/2000 – 03/2015 Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany
  • Senior scientist, Laboratory of Immunotherapy: 10/1994 - 09/2000 Dept. of Internal Medicine I, University of Cologne, Germany
  • Research associate, Ph.D. student: 10/1992 - 09/1994 Institute for Molecular Physiology and Biotechnology of Plants at the University of Bonn, Germany

Temporary Employment Abroad

01/1993 - 04/1993 Kennedy Space Center, Cape Canaveral, Florida

Additional Qalifications

2001 Workshop, Project management for EU projects
1994 Project leader according to § 15 (2) and (4) GenTSV (allowing operation of S2 gene technology laboratories according to German law)



Stefan Barth

South African Research Chair in Cancer Biotechnology

  • Institute of Infectious Disease and Molecular Medicine
    University of Cape Town
  • COUNTRY South Africa